Lv2
122 积分 2025-10-10 加入
Astragaloside IV inhibits the progression of hypertensive heart disease via the RXRA/PPARG/SIRT3 axis
28天前
已完结
Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2
28天前
已完结
Quercetin liposomes targeting neutrophils suppresses NETosis: A therapeutic strategy against liver fibrosis
28天前
已完结
Epithelial-to-mesenchymal transition as a central driver of tumor cell plasticity
30天前
已完结
Manganese‐Chelating L‐Serine Nanoarchitectures: Targeting Kidney Injury Molecule‐1 for Reversing Renal Ischemia‐Reperfusion Injury via Senescence Regulation
30天前
已完结
Molecular Pathway Modulation and Nanotechnology‐Based Therapeutic Strategies for Shikonin
30天前
已完结
Cell–cell crosstalk in kidney health and disease
1个月前
已完结
Cell–cell crosstalk in kidney health and disease
1个月前
已完结
Podocyte-targeted therapies — progress and future directions
1个月前
已完结
Metabolism at the crossroads of inflammation and fibrosis in chronic kidney disease
1个月前
已完结
皖公网安备34019202002308
